This map shows the geographic impact of Mark Dugall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dugall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dugall more than expected).
This network shows the impact of papers produced by Mark Dugall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dugall. The network helps show where Mark Dugall may publish in the future.
Co-authorship network of co-authors of Mark Dugall
This figure shows the co-authorship network connecting the top 25 collaborators of Mark Dugall.
A scholar is included among the top collaborators of Mark Dugall based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Mark Dugall. Mark Dugall is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Feragalli, Beatrice, E. Ippolito, Mark Dugall, et al.. (2017). Effectiveness of a novel boswellic acids delivery form (Casperome®) in the management of grade II ankle sprains due to sport trauma - a registry study.. PubMed. 21(20). 4726–4732.4 indexed citations
7.
Hu, Shenqiang, G Belcaro, Mark Dugall, et al.. (2016). Aescin-based topical formulation to prevent foot wounds and ulcerations in diabetic microangiopathy.. PubMed. 20(20). 4337–4342.3 indexed citations
8.
Belcaro, G, Mark Dugall, Marcello Corsi, Giovanni B. Agus, & E. Ippolito. (2016). Superficial venous incompetence: low-cost outpatient minisurgery, sclerotherapy and combined procedure as a management plan. Costs and efficacy. A 20-year, follow-up registry.. PubMed. 71(4). 223–32.2 indexed citations
9.
Belcaro, G, Mark Dugall, Shen Hu, et al.. (2015). Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study.. PubMed. 57(3). 121–5.5 indexed citations
10.
Belcaro, Gianni, Mark Dugall, Masako Hosoi, et al.. (2014). Pycnogenol® and Centella Asiatica for asymptomatic atherosclerosis progression.. PubMed. 33(1). 20–6.15 indexed citations
Vinciguerra, G., G Belcaro, Enrica Bonanni, et al.. (2013). Evaluation of the effects of supplementation with Pycnogenol® on fitness in normal subjects with the Army Physical Fitness Test and in performances of athletes in the 100-minute triathlon.. PubMed. 53(6). 644–54.9 indexed citations
Ledda, A, Gianni Belcaro, Mark Dugall, et al.. (2012). Meriva®, a lecithinized curcumin delivery system, in the control of benign prostatic hyperplasia: a pilot, product evaluation registry study.. PubMed. 54(1 Suppl 4). 17–22.38 indexed citations
15.
Belcaro, Gianni, B.M. Errichi, Mark Dugall, et al.. (2010). Venous and diabetic ulcerations: management with topical multivalent silver oxide ointment.. PubMed. 52(2 Suppl 1). 37–42.17 indexed citations
Vinciguerra, G., G Belcaro, Cesarone Mr, et al.. (2008). Management of uncomplicated ankle sprains with topical or oral ketoprofen treatment. A registry study.. PubMed. 56(5 Suppl). 47–53.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.